Home LiteratureArticle Details
PMID: 8092816 Published · ppublish English Journal Article Review

Clinical relevance of antibiotic-induced endotoxin release.

Antimicrobial agents and chemotherapy ·Vol. 38 ·No. 6 ·1994-06-00 ·Pages 1211-8

Prins JM, van Deventer SJ, Kuijper EJ, Speelman P

Abstract

暂无摘要

MeSH Terms
Animals Anti-Bacterial Agents/metabolism,pharmacology,therapeutic use Endotoxins/metabolism Gram-Negative Bacterial Infections/drug therapy,metabolism Humans
Chemicals
Anti-Bacterial Agents Endotoxins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Prins J M
Department of Internal Medicine, Academisch Medisch Centrum, Amsterdam, The Netherlands.
van Deventer S J
Kuijper E J
Speelman P
References (79)
79 references, click to expand
  1. Carbapenems: special properties contributing to their activity.
    Am J Med. 1985 Jun 7;78(6A):33-40 PMID: 3873871
  2. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
    Am J Med. 1985 Aug 9;79(2A):2-13 PMID: 3895915
  3. Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide.
    Antimicrob Agents Chemother. 1985 Jul;28(1):107-12 PMID: 2412488
  4. Effect of methylprednisolone on bacterial clearance and endotoxin liberation during experimental sepsis induced by gram-negative bacteria.
    Infect Immun. 1986 Apr;52(1):26-30 PMID: 3957427
  5. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B.
    Eur J Clin Microbiol. 1986 Feb;5(1):13-7 PMID: 3009177
  6. Protective effect of subinhibitory polymyxin B alone and in combination with ampicillin for overwhelming Haemophilus influenzae type B infection in the infant rat: evidence for in vivo and in vitro release of free endotoxin after ampicillin treatment.
    Pediatr Res. 1986 Mar;20(3):237-41 PMID: 3010223
  7. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin.
    Antimicrob Agents Chemother. 1986 Mar;29(3):496-500 PMID: 3013085
  8. Evaluation for endotoxemia in patients receiving penicillin therapy for secondary syphilis.
    JAMA. 1986 Jul 18;256(3):388-90 PMID: 3723728
  9. Penicillin-binding proteins and the antibacterial effectiveness of beta-lactam antibiotics.
    Rev Infect Dis. 1986 Jul-Aug;8 Suppl 3:S260-78 PMID: 3092301
  10. Control of lipopolysaccharide biosynthesis and release by Escherichia coli and Salmonella typhimurium.
    J Bacteriol. 1986 Oct;168(1):328-33 PMID: 3531174
  11. Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli.
    Antimicrob Agents Chemother. 1986 Nov;30(5):659-63 PMID: 3541782
  12. Release of endotoxin from Escherichia coli by quinolones.
    J Antimicrob Chemother. 1986 Dec;18(6):765-6 PMID: 3546245
  13. Protection from endotoxemia: a rat model of plasmapheresis and specific adsorption with polymyxin B.
    J Infect Dis. 1987 Apr;155(4):690-5 PMID: 3029243
  14. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits.
    J Infect Dis. 1987 Sep;156(3):456-62 PMID: 3302052
  15. Effect of antibiotics on gram-negative sepsis in the rat. Lack of endotoxin burst.
    Acta Chir Scand. 1987 Apr;153(4):283-6 PMID: 3307255
  16. Polymyxin B moderates acidosis and hypotension in established, experimental gram-negative septicemia.
    J Infect Dis. 1987 Nov;156(5):706-12 PMID: 2821123
  17. Endotoxin liberation from Neisseria meningitidis isolated from carriers and clinical cases.
    Scand J Infect Dis. 1987;19(4):409-19 PMID: 3118451
  18. Reactivity of antibodies to core glycolipid with gram-negative bacteria.
    Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S639-43 PMID: 2446371
  19. Increased plasma levels of endotoxin and corresponding changes in circulatory performance in a porcine sepsis model: the effect of antibiotic administration.
    Prog Clin Biol Res. 1988;272:247-62 PMID: 3393566
  20. Endotoxin interactions with serum proteins relationship to biological activity.
    Prog Clin Biol Res. 1988;272:47-62 PMID: 3393572
  21. The metabolic fate of endotoxins.
    Prog Clin Biol Res. 1988;272:63-75 PMID: 3393573
  22. Immunolabeling of lipopolysaccharide liberated from antibiotic-treated Escherichia coli.
    Infect Immun. 1988 Oct;56(10):2760-2 PMID: 3047065
  23. Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat.
    J Clin Invest. 1988 Oct;82(4):1339-46 PMID: 3262627
  24. Penicillin-binding proteins of gram-negative bacteria.
    Rev Infect Dis. 1988 Jul-Aug;10(4):699-711 PMID: 3055170
  25. Effects of aminoglycosides and spectinomycin on the synthesis and release of lipopolysaccharide by Escherichia coli.
    Antimicrob Agents Chemother. 1988 Aug;32(8):1247-50 PMID: 2973285
  26. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease.
    J Infect Dis. 1989 Feb;159(2):195-204 PMID: 2492587
  27. Polymyxin B prevents lipopolysaccharide-induced release of tumor necrosis factor-alpha from alveolar macrophages.
    J Infect Dis. 1989 Jul;160(1):52-7 PMID: 2543712
  28. Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis.
    J Infect Dis. 1989 Nov;160(5):818-25 PMID: 2809257
  29. Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy.
    J Infect Dis. 1989 Nov;160(5):891-5 PMID: 2809260
  30. Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide.
    Antimicrob Agents Chemother. 1989 Sep;33(9):1428-34 PMID: 2554795
  31. Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone.
    J Infect Dis. 1989 Dec;160(6):1005-11 PMID: 2584749
  32. Inhibition of endotoxin reactivity by aminoglycosides.
    J Antimicrob Chemother. 1989 Nov;24(5):826-8 PMID: 2600005
  33. Release of endotoxin after antibiotic treatment of Gram-negative bacterial meningitis.
    Pediatr Infect Dis J. 1989 Dec;8(12):904-6 PMID: 2626299
  34. Postantibiotic effect of beta-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP.
    Antimicrob Agents Chemother. 1990 Jan;34(1):102-6 PMID: 2183707
  35. Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae.
    J Antimicrob Chemother. 1990 Apr;25(4):525-34 PMID: 2351623
  36. Structure and function of lipopolysaccharide binding protein.
    Science. 1990 Sep 21;249(4975):1429-31 PMID: 2402637
  37. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
    Science. 1990 Sep 21;249(4975):1431-3 PMID: 1698311
  38. Antibiotics versus cardiovascular support in a canine model of human septic shock.
    Am J Physiol. 1990 Nov;259(5 Pt 2):H1440-7 PMID: 2240243
  39. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock.
    Chest. 1990 Dec;98(6):1480-7 PMID: 2245691
  40. Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in Limulus activity.
    Infect Immun. 1991 Feb;59(2):689-95 PMID: 1898913
  41. Effect of penicillin and chloramphenicol on the growth and endotoxin release by N. meningitidis.
    Epidemiol Infect. 1991 Apr;106(2):283-8 PMID: 1902182
  42. Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins.
    J Infect Dis. 1991 Sep;164(3):542-9 PMID: 1908001
  43. The pathogenesis of sepsis.
    Ann Intern Med. 1991 Sep 15;115(6):457-69 PMID: 1872494
  44. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli.
    J Infect Dis. 1991 Oct;164(4):800-2 PMID: 1894940
  45. Aminoglycosides modify the in vitro metachromatic reaction and murine generalized Shwartzman phenomenon induced by Salmonella minnesota R595 lipopolysaccharide.
    Antimicrob Agents Chemother. 1991 Oct;35(10):2161-4 PMID: 1759842
  46. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    J Immunol. 1992 Jan 15;148(2):532-7 PMID: 1729370
  47. Antibiotic-induced release of endotoxin in chronically bacteriuric patients.
    Antimicrob Agents Chemother. 1991 Nov;35(11):2388-94 PMID: 1804012
  48. beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime.
    J Infect Dis. 1992 Jun;165(6):1033-41 PMID: 1583320
  49. Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gram-negative meningitis?
    J Infect Dis. 1992 Jun;165 Suppl 1:S82-5 PMID: 1588187
  50. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study.
    Scand J Infect Dis. 1991;23(6):745-54 PMID: 1815338
  51. Teicoplanin reduces in-vitro reactivity and murine lethality of Salmonella minnesota R595 lipopolysaccharide.
    J Antimicrob Chemother. 1992 Apr;29(4):443-6 PMID: 1535068
  52. Bactericidal activity of beta-lactams and amikacin against Haemophilus influenzae: effect on endotoxin release.
    J Antimicrob Chemother. 1992 Aug;30(2):165-72 PMID: 1399926
  53. Antibiotic-induced release of endotoxin: a reappraisal.
    Clin Infect Dis. 1992 Nov;15(5):840-54 PMID: 1445982
  54. Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release.
    Scand J Infect Dis. 1992;24(5):619-27 PMID: 1465580
  55. Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood.
    J Infect Dis. 1993 Jan;167(1):240-4 PMID: 8418175
  56. Effect of antibiotics on endotoxin release from gram-negative bacteria.
    Diagn Microbiol Infect Dis. 1993 Mar-Apr;16(3):185-9 PMID: 8477572
  57. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes.
    J Antimicrob Chemother. 1993 Mar;31(3):373-84 PMID: 8486571
  58. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Immunobiology. 1993 Apr;187(3-5):417-29 PMID: 8330906
  59. Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis.
    J Infect Dis. 1993 Sep;168(3):657-62 PMID: 8354907
  60. Inactivation of endotoxin by polymyxin B.
    Antimicrob Agents Chemother. 1974 Oct;6(4):422-5 PMID: 4157338
  61. Electron microscopy of effect of polymyxin on Escherichia coli lipopolysaccharide.
    J Bacteriol. 1969 Nov;100(2):1128-9 PMID: 4311679
  62. Endotoxin-induced intravascular coagulation: prevention with polymyxin B sulfate.
    J Lab Clin Med. 1971 May;77(5):802-10 PMID: 4326749
  63. Neutralization of the hemodynamic effects of endotoxin by polymyxin B.
    Surg Gynecol Obstet. 1974 May;138(5):755-9 PMID: 4362912
  64. Inhibition of the biologic effects of endotoxin on neutrophils by polymyxin B sulfate.
    J Infect Dis. 1977 Oct;136(4):469-74 PMID: 198485
  65. Frapper fort ou frapper doucement: a gram-negative dilemma.
    Lancet. 1978 Dec 2;2(8101):1193-4 PMID: 82154
  66. Effect of polymyxin B sulfate on endotoxin activity in a gram-negative septicemia model.
    Pediatr Res. 1979 Jan;13(1):48-51 PMID: 219410
  67. Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs.
    Infect Immun. 1979 Mar;23(3):660-4 PMID: 222676
  68. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits.
    J Immunol. 1979 Nov;123(5):2133-43 PMID: 489976
  69. Cytotoxicity of human macrophages for tumor cells: enhancement by bacterial lipopolysaccharides (LPS).
    J Immunol. 1980 Feb;124(2):708-12 PMID: 7356710
  70. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.
    Am J Med. 1980 Mar;68(3):344-55 PMID: 6987871
  71. Liberation of endotoxin from Escherichia coli by addition of antibiotics.
    Jpn J Exp Med. 1980 Feb;50(1):35-43 PMID: 6991738
  72. Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin.
    Br J Pharmacol. 1981 Nov;74(3):701-7 PMID: 6170378
  73. Effect of immune serum or polymyxin B on Escherichia coli-induced inflammation and vascular injury.
    Infect Immun. 1982 May;36(2):548-57 PMID: 6282752
  74. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.
    Microbiol Rev. 1983 Mar;47(1):46-83 PMID: 6343827
  75. Spontaneous release of lipopolysaccharide by Pseudomonas aeruginosa.
    J Bacteriol. 1983 Aug;155(2):817-25 PMID: 6409883
  76. Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death.
    Am J Med. 1983 Aug 29;75(2A):9-20 PMID: 6311012
  77. Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.
    J Infect Dis. 1984 Sep;150(3):380-8 PMID: 6384378
  78. Effect of benzylpenicillin in mice infected with endotoxin-liberating or non-liberating variant strains of Neisseria meningitidis.
    Scand J Infect Dis. 1984;16(3):257-66 PMID: 6436963
  79. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.
    J Infect Dis. 1985 Jun;151(6):1012-8 PMID: 3889171
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
DOI
10.1128/AAC.38.6.1211
Published
1994-06-00
Pages
1211-8
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC188188
Subset
IM
External Links
PubMed source DOI: 10.1128/AAC.38.6.1211 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2